Clinical Trials Logo

Atrial Arrhythmia clinical trials

View clinical trials related to Atrial Arrhythmia.

Filter by:

NCT ID: NCT06293430 Not yet recruiting - Atrial Fibrillation Clinical Trials

Registry on Luma Vision's VERAFEYE System (ENLIgHT)

ENLIgHT
Start date: September 15, 2024
Phase:
Study type: Observational

The objective of the study is to compile real-world data on the use of the VERAFEYE System in standard of care atrial fibrillation (AF) ablation procedures and left atrial appendage closure (LAAC) procedures. Results from this study will be used to guide development of the VERAFEYE System.

NCT ID: NCT06223789 Recruiting - Atrial Fibrillation Clinical Trials

VOLT-AF IDE Clinical Study

Start date: April 3, 2024
Phase: N/A
Study type: Interventional

This clinical investigation is intended to demonstrate safety and effectiveness of the Volt™ Pulsed Field Ablation (PFA) Catheter Sensor Enabled™, the Volt™ PFA Generator, Agilis™ NxT Steerable Introducer Dual-Reach™, and EnSite™ X EP System EnSite™ Pulsed Field Ablation Module (for simplicity of reference this device collection will hereafter be referred to as the Volt™ PFA system) for the treatment of symptomatic, recurrent, drug-refractory paroxysmal and persistent atrial fibrillation.

NCT ID: NCT06165510 Not yet recruiting - Clinical trials for Persistent Atrial Fibrillation

Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation

CLIP-AF
Start date: January 2024
Phase: N/A
Study type: Interventional

A randomised controlled clinical trial to assess efficacy of convergent ablation with the LARIAT procedure, as compared to standard endocardial catheter ablation in patients with long-standing persistent atrial fibrillation (AF).

NCT ID: NCT06151132 Completed - Clinical trials for Cardiovascular Diseases

Treatment of Atrial Fibrillation in the Community Settings

Start date: January 1, 2016
Phase:
Study type: Observational

Description of treatment of cardiovascular diseases in community settings in Russia

NCT ID: NCT06083012 Recruiting - Atrial Fibrillation Clinical Trials

Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation

COMRADE-AI
Start date: October 27, 2023
Phase:
Study type: Observational

The goal of this Observational Prospective Multi-center Study is to observe the acute and long-term safety and performance outcomes after spatiotemporal dispersion-based AF/AT ablation utilizing the Volta Medical AI software in "real-life" clinical practice, without any imposed clinical workflow. Moreover, this study will allow to collect medico-economic data related to the tailored ablation strategy guided by the Volta Medical AI software.

NCT ID: NCT05931835 Not yet recruiting - Atrial Fibrillation Clinical Trials

Feasibility Study on the VERAFEYE System

LUMINIzE
Start date: August 15, 2024
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the performance of the VERAFEYE System in subjects entitled to undergo a standard of care ablation or closure procedure. Results from this study will be used to guide development and refinement the VERAFEYE System. The study is not designed to collect data for product approval and as such does not have a safety or efficacy endpoint.

NCT ID: NCT05883631 Recruiting - Atrial Fibrillation Clinical Trials

RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

RESOLVE-AF
Start date: October 23, 2023
Phase: N/A
Study type: Interventional

Demonstrate the safety and effectiveness of the Ablacath™ Mapping Catheter and Ablamap® System in patients with all types of atrial fibrillation (AF) including paroxysmal or persistent or long-standing persistent, undergoing and De Novo or Redo procedures. Phenotype patients and demonstrate the prognostication power of Electrographic Flow (EGF®) maps among all subjects using 12-month follow-up outcomes following EGF-guided mapping and ablation.

NCT ID: NCT05526170 Recruiting - Atrial Fibrillation Clinical Trials

Triggers and Risk Factors for Recurrence of Atrial Arrhythmias With the Use of Long-term Monitoring

TriggersAF
Start date: August 1, 2021
Phase:
Study type: Observational

A prospective cohort study to evaluate the association between various triggers encountered in daily life and induction of atrial arrhythmias (atrial fibrillation, atrial flutter, atrial tachycardia and premature atrial contractions) with the use of long-term monitoring devices. The collected data of personalized triggers and risk factors will be used to define the individual phenotype of atrial arrhythmia.

NCT ID: NCT05488470 Recruiting - Clinical trials for Arrhythmias, Cardiac

QT Changes as Detected From LINQ ECG During and After Antiarrhythmic Loading (LINQ QT)

LINQ QT
Start date: January 31, 2023
Phase:
Study type: Observational

The LINQ QT Study is a prospective, non-randomized, multi-center, observational, post-market clinical study investigating QT interval changes due to antiarrhythmic drug loading.

NCT ID: NCT05434650 Recruiting - Atrial Arrhythmia Clinical Trials

Abbott Atrial Fibrillation Post Approval Study

Start date: October 21, 2022
Phase:
Study type: Observational

This post-approval study is designed to provide continued real-world clinical evidence to confirm the safety and long-term effectiveness of atrial fibrillation (AF) radiofrequency (RF) technologies (e.g. TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE)) for the treatment of AF.